Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Clinical trial NCT05410860 · COMPLETED
Trial details
- NCT number
- NCT05410860
- Sponsor
- Corxel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-08-02
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.